Cargando…

The Tri-iodothyronine (T3) Level Is a Prognostic Factor for Patients With Advanced NSCLC: Receiving Immune Checkpoint Inhibitors and Is Associated With Liver Metastasis

BACKGROUND: Endocrine hormones influence tumor progression and the response to treatment. Despite the importance of immune checkpoint inhibitors (ICIs) as treatments for advanced non-small cell lung cancer (NSCLC), few studies have explored the effects of hormone levels in NSCLC patients on the effe...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kim, Yoonjoo, Koh, Jeong Suk, Woo, Seong-Dae, Lee, Song-I, Kang, Da Hyun, Park, Dongil, Chung, Chaeuk, Kwon, In-Sun, Lee, Jeong Eun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2022
Materias:	Original Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9751177/ https://www.ncbi.nlm.nih.gov/pubmed/36532699 http://dx.doi.org/10.1177/11795549221139522

Ejemplares similares

The rest period between chemotherapy and immunotherapy influences the efficacy of immune checkpoint inhibitors in lung cancer
por: Kang, Da Hyun, et al.
Publicado: (2022)

Antithrombin and free tri-iodothyronine in sepsis
por: Mateu, P, et al.
Publicado: (2004)

Immune checkpoint inhibitor therapy in a patient with small cell lung cancer and anti‐transcriptional intermediary factor 1‐γ antibody‐positive dermatomyositis: A case report
por: Kim, Yoonjoo, et al.
Publicado: (2022)

Early detection of delayed pneumothorax using lung ultrasound after transthoracic needle lung biopsy: A prospective pilot study
por: Koh, Jeong Suk, et al.
Publicado: (2022)

Right middle lobe obstruction associated with synchronous endobronchial carcinoid and aspergillosis
por: Kim, Yoonjoo, et al.
Publicado: (2021)

Transthoracic Needle Biopsy: How to Maximize Diagnostic Accuracy and Minimize Complications
por: Chung, Chaeuk, et al.
Publicado: (2020)

Circulating regulatory T cells predict efficacy and atypical responses in lung cancer patients treated with PD-1/PD-L1 inhibitors
por: Kang, Da Hyun, et al.
Publicado: (2021)

Can Thyrotropin, Tri-Iodothyronine, and Thyroxine Hormones be Predictors of Cancer in Thyroid Lesions?
por: Khider, Mohamed O, et al.
Publicado: (2022)

High levels of maternal total tri-iodothyronine, and low levels of fetal free L-thyroxine and total tri-iodothyronine, are associated with altered deiodinase expression and activity in placenta with gestational diabetes mellitus
por: Gutiérrez-Vega, Sebastián, et al.
Publicado: (2020)

A Clinical Trial of Tri-Iodothyronine as a Hormone Potentiator in Advanced Breast Cancer
por: Stoll, B. A.
Publicado: (1962)

The Role of Hypothalamic Tri-Iodothyronine Availability in Seasonal Regulation of Energy Balance and Body Weight
por: Murphy, Michelle, et al.
Publicado: (2011)

The Inhibitory Effect of Salmon Calcitonin on Tri-Iodothyronine Induction of Early Hypertrophy in Articular Cartilage
por: Chen-An, Pingping, et al.
Publicado: (2012)

New Insights into the Clinical Implications of Yes-Associated Protein in Lung Cancer: Roles in Drug Resistance, Tumor Immunity, Autophagy, and Organoid Development
por: Yoo, Geon, et al.
Publicado: (2021)

(Healthy) Ageing: Focus on Iodothyronines
por: de Lange, Pieter, et al.
Publicado: (2013)

Comparative Study of Alterations in Tri-iodothyronine (T3) and Thyroxine (T4) Hormone Levels in Breast and Ovarian Cancer
por: Rasool, Mahmood, et al.
Publicado: (2014)

The coming era of a new auscultation system for analyzing respiratory sounds
por: Kim, Yoonjoo, et al.
Publicado: (2022)

Iodothyronine deiodinase enzyme activities in bone
por: Williams, Allan J., et al.
Publicado: (2008)

Comparison of serum levels of Tri‐iodothyronine (T3), Thyroxine (T4), and Thyroid‐Stimulating Hormone (TSH) in preeclampsia and normal pregnancy
por: Khadem, Nayereh, et al.
Publicado: (2012)

Is It T3 Thyrotoxicosis? A Case of Falsely Elevated Tri-Iodothyronine (T3) Levels Leading to a Diagnosis of Multiple Myeloma
por: Ram, Nanik, et al.
Publicado: (2019)

Evolution of the Stethoscope: Advances with the Adoption of Machine Learning and Development of Wearable Devices
por: Kim, Yoonjoo, et al.
Publicado: (2023)

Thyroxine binding to type III iodothyronine deiodinase
por: Bayse, Craig A., et al.
Publicado: (2020)

Changes in Oxygenation and Serological Markers in Acute Exacerbation of Interstitial Lung Disease Treated with Polymyxin B Hemoperfusion
por: Lee, Song-I, et al.
Publicado: (2022)

Scientific Validation and Clinical Application of Lung Cancer Organoids
por: Lee, Dahye, et al.
Publicado: (2021)

Preoperative low tri-iodothyronine concentration is associated with worse health status and shorter five year survival of primary brain tumor patients
por: Bunevicius, Adomas, et al.
Publicado: (2016)

Effect of Iodothyronines on Thermogenesis: Focus on Brown Adipose Tissue
por: Cioffi, Federica, et al.
Publicado: (2018)

Regulation of type 1 iodothyronine deiodinase by LXRα
por: Sakane, Yoriko, et al.
Publicado: (2017)

A Halogen Bonding Perspective on Iodothyronine Deiodinase Activity
por: Marsan, Eric S., et al.
Publicado: (2020)

The Influence of Sex on Characteristics and Outcomes of Coronavirus-19 Patients: A Retrospective Cohort Study
por: Lee, Song-I, et al.
Publicado: (2023)

Plasma GDF15 levels associated with circulating immune cells predict the efficacy of PD-1/PD-L1 inhibitor treatment and prognosis in patients with advanced non-small cell lung cancer
por: Hong, Green, et al.
Publicado: (2022)

Enzymatic activity of type 1 iodothyronine deiodinase in selected liver tumors
por: Kornasiewicz, Oskar, et al.
Publicado: (2013)

Pulmonary lymphangioleiomyomatosis and renal angiomyolipoma in a patient with systemic lupus erythematosus: A case report
por: Koh, Jeong Suk, et al.
Publicado: (2022)

Reduced FEV(1) as Prognostic Factors in Patients With Advanced NSCLC Receiving Immune Checkpoint Inhibitors
por: Shen, Yi-Luen, et al.
Publicado: (2022)

Cosuppression of NF-κB and AICDA Overcomes Acquired EGFR-TKI Resistance in Non-Small Cell Lung Cancer
por: Yeo, Min-Kyung, et al.
Publicado: (2022)

A patient with a lung adenosquamous carcinoma harboring a de novo T790M mutation and huge nonbacterial vegetative growths successfully treated with osimertinib: A case report
por: Kim, So‐yun, et al.
Publicado: (2023)

SAT-564 The Role Of Se Recycling In Regulating Iodothyronine-deiodinases In The Skeletal Muscle
por: Ogawa-Wong, Ashley, et al.
Publicado: (2019)

Spontaneous regression of incidentally diagnosed bronchial squamous cell lung carcinoma after severe bronchitis: A case report
por: Kim, Yoonjoo, et al.
Publicado: (2021)

Practical challenges in patients with stage III NSCLC receiving checkpoint inhibitors after chemoradiation
por: Shukla, Nikhil A, et al.
Publicado: (2020)

Cryobiopsy: A Breakthrough Strategy for Clinical Utilization of Lung Cancer Organoids
por: Park, Dongil, et al.
Publicado: (2023)

Safety and Efficacy of Bojungikki-Tang in Advanced NSCLC Patients Receiving Treatment with Immune Checkpoint Inhibitors: Protocol for a Multicenter, Double-Blind, Randomized, Placebo-Controlled Pilot Trial
por: Ko, Mi Mi, et al.
Publicado: (2023)

Effects of Perfluorooctane Sulfonate on Cerebellar Cells via Inhibition of Type 2 Iodothyronine Deiodinase Activity
por: Fujiwara, Yuki, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_qhj0d4akidklg3lb9vuo3hug47